October Pharma S.A.E (EGX:OCPH)
Egypt
· Delayed Price · Currency is EGP 112.25
0.00 (0.00%)
At close: Jun 25, 2025
October Pharma S.A.E Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 158.98 | 151.84 | 182.13 | 130.75 | 119.79 | 88.26 | Upgrade
|
| Depreciation & Amortization | 33.02 | 30.12 | 22.51 | 22 | 20.8 | 18.82 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.21 | -4.1 | -0.24 | -0.34 | - | -0.05 | Upgrade
|
| Provision & Write-off of Bad Debts | 11.97 | 7.78 | 5.76 | 0.94 | 2.21 | - | Upgrade
|
| Other Operating Activities | 145.85 | 123.98 | 102.07 | 42.76 | 55.6 | 40.1 | Upgrade
|
| Change in Accounts Receivable | 3.53 | -26.82 | -70.98 | -49.56 | -12.86 | -11.11 | Upgrade
|
| Change in Inventory | -147.65 | -154.32 | 84.44 | -89.2 | -26.75 | -52.84 | Upgrade
|
| Change in Accounts Payable | 44.51 | 68.24 | -10.28 | 50.46 | -4.59 | -2.45 | Upgrade
|
| Change in Other Net Operating Assets | -173.92 | -153.5 | -162.12 | -200.13 | 107.93 | -27.44 | Upgrade
|
| Operating Cash Flow | 75.08 | 43.24 | 153.29 | -92.33 | 262.13 | 53.3 | Upgrade
|
| Operating Cash Flow Growth | -50.27% | -71.79% | - | - | 391.81% | -44.52% | Upgrade
|
| Capital Expenditures | -28.25 | -53.06 | -35.31 | -92.67 | -19.7 | -5.65 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.22 | 4.11 | 0.25 | 0.36 | - | 0.05 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.35 | -1.99 | -1.7 | -1.38 | Upgrade
|
| Investing Cash Flow | -27.02 | -48.94 | -35.4 | -94.31 | -21.4 | -6.98 | Upgrade
|
| Short-Term Debt Issued | - | 210.52 | 13.69 | 188.26 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 60.92 | - | - | Upgrade
|
| Total Debt Issued | 181.24 | 210.52 | 13.69 | 249.19 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -136.65 | -2.4 | Upgrade
|
| Long-Term Debt Repaid | - | -11.24 | -12.47 | - | -24.83 | -12.02 | Upgrade
|
| Total Debt Repaid | -29.76 | -11.24 | -12.47 | - | -161.48 | -14.42 | Upgrade
|
| Net Debt Issued (Repaid) | 151.47 | 199.28 | 1.22 | 249.19 | -161.48 | -14.42 | Upgrade
|
| Common Dividends Paid | -55.48 | -55.48 | -17.95 | -44.66 | -34.19 | -14.86 | Upgrade
|
| Other Financing Activities | -138.68 | -130.86 | -62.77 | -27.7 | -30.2 | -31.91 | Upgrade
|
| Financing Cash Flow | -42.68 | 12.94 | -79.51 | 176.83 | -225.87 | -61.18 | Upgrade
|
| Net Cash Flow | 5.38 | 7.23 | 38.38 | -9.81 | 14.86 | -14.86 | Upgrade
|
| Free Cash Flow | 46.84 | -9.82 | 117.98 | -185 | 242.43 | 47.65 | Upgrade
|
| Free Cash Flow Growth | -55.26% | - | - | - | 408.80% | -24.17% | Upgrade
|
| Free Cash Flow Margin | 3.50% | -0.80% | 11.66% | -25.43% | 37.01% | 8.77% | Upgrade
|
| Free Cash Flow Per Share | 3.90 | -0.82 | 9.83 | -15.42 | 20.20 | 3.97 | Upgrade
|
| Cash Interest Paid | 130.86 | 130.86 | 62.77 | - | 30.2 | 31.91 | Upgrade
|
| Cash Income Tax Paid | 61.55 | 61.55 | 41.29 | 37.37 | 22.7 | 10.53 | Upgrade
|
| Levered Free Cash Flow | -5.3 | -86.83 | 25.35 | -239 | 200.33 | -9.99 | Upgrade
|
| Unlevered Free Cash Flow | 81.37 | -5.05 | 64.58 | -221.68 | 219.2 | 9.95 | Upgrade
|
| Change in Net Working Capital | 146.47 | 182.47 | 114.19 | 273.54 | -97.59 | 92.49 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.